Sterile Chemical Peritonitis Secondary to Icodextrin: Immunohistopathological Description

Mistry C.D. , Gokal R. , Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int 1994; 46: 496–503.

Mistry C.D. , Mallick N.P. , Gokal R. Ultrafiltration with isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii: 178–82.

Plum J. , Gentile S. , Verger C. , Brunkhorst R. , Bahner U. , Faller B. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39: 862–71.

Pinerolo M.C. , Porri M.T. , D'Amico G. Recurrent sterile peritonitis at onset of treatment with icodextrin solution. Perit Dial Int 1999; 19: 491–2.

Heering P. , Brause M. , Plum J. , Grabensee B. Peritoneal reaction to icodextrin in a female patient on CAPD. Perit Dial Int 2001; 21: 321–2.

Del Rosso G. , Di Liberato L. , Perilli A. , Cappelli P. , Bonomini M. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient. Nephrol Dial Transplant 2000; 15: 927–8.

Reichel W. , Schulze B. , Dietze J. , Mende W. A case of sterile peritonitis associated with icodextrin solution. Perit Dial Int 2001; 21: 414–19.

Williams P.F. , Foggensteiner L. Sterile/allergic peritonitis with icodextrin in CAPD patients. Perit Dial Int 2002; 22: 89–90.

Goffin E. , Scheiff J.M. Transient sterile chemical peritonitis in a CAPD patient using icodextrin. Perit Dial Int 2002; 22: 90–1.

Tintillier M. , Pochet J.M. , Christophe J.L. , Scheiff J.M. , Goffin E. Transient sterile chemical peritonitis with icodextrin: Clinical presentation, prevalence, and literature review. Perit Dial Int 2002; 22: 534–7.

Goffin E. , Pouthier D. , Vandercam B. , Gigi J. IV vancomycin-oral ciprofloxacin: A safe and efficient therapeutic protocol for CAPD peritonitis (preliminary report). Perit Dial Int 1996; 16: 174–7.

Twardowski Z.J. , Nolph K.D. , Khanna R. , Prowant B.F. , Ryan L.P. , Moore H.L. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138–47.

Combet S. , Van Landschoot M. , Moulin P. , Piech A. , Verbavatz J.M. , Goffin E. Regulation of aquaporin-1 and nitric oxide synthase in a rat model of acute peritonitis. J Am Soc Nephrol 1999; 10: 2185–96.

Flanigan M.J. , Freeman R.M. , Lim V.S. Cellular response to peritonitis among peritoneal dialysis patients. Am J Kidney Dis 1985; 6: 420–4.

Di Paolo N. , Sacchi G. Peritonitis. Atlas of peritoneal histology. Perit Dial Int 2000; 20(Suppl 3): S64–86.

St C Barnetson R. , Gawkrodger D. Hypersensitivity — type IV. In: Roitt I. , Brostoff J. , Male D. , eds. Immunology. Philadelphia: Lippincott; 1989.

Extraneal — cloudy effluent investigations. Justifications used in establishing a safety limit for peptidoglycan in Extraneal. Letter from Baxter to Nephrologists in Europe. 22 May 2002.

Van Heijenoort J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001; 11: 25R–36R.

Nakagawa Y. , Maeda H. , Murai T. Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: Comparison with a human whole blood culture test system and with the rabbit pyrogen test. Clin Diagn Lab Immunol 2002; 9: 588–97.

Freiman J.P. , Graham D.J. , Greene Reed T. , McGoodwin E.B. Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12: 57–60.